The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy
- 作者Donald V. Unverferth; Raymond D. Magorien; Ruth Altschuld; Albert J. Kolibash; Richard P. Lewis; Carl V. Leier
- 卷第106卷
- 印刷ISSN0002-8703
- 电子ISSN1097-6744
- 文件大小715.77KB
- 发表时间1983
- DOI10.1016/0002-8703(83)90434-9
Biochemical measurements of endomyocardial biopsiesDonald V. Unverferth; Richard H. Fertel; Ruth Altschuld; Raymond D. Magorien; Richard P. Lewis; Carl V. Leier · 1981
Reproducibility of echocardiography in chronic congestive heart failureDonald V. Unverferth; Richard P. Lewis; Carl V. Leier; Raymond D. Magorien; Phillip K. Fulkerson · 1980
Long-term benefit of dobutamine in patients with congestive cardiomyopathyDonald V. Unverferth; Raymond D. Magorien; Richard P. Lewis; Carl V. Leier · 1980
Positive inotropic effects of hydralazine in human subjects: Comparison with prazosin in the setting of congestive heart failureCarl V. Leier; Christopher E. Desch; Raymond D. Magorien; Douglas W. Triffon; Donald V. Unverferth; Harisios Boudoulas; Richard P. Lewis · 1980
The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathyDonald V. Unverferth; Raymond D. Magorien; Ruth Altschuld; Albert J. Kolibash; Richard P. Lewis; Carl V. Leier · 1983